newsfilter
← Latest News
PR Newswire·

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 ...